P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Trials: Safety and Inter-ethnic Comparison of Pharmacokinetics in Healthy Chinese and Japanese Participants
Article in Clinical Pharmacokinetics (June 2024)
The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.
Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
Article in BMC Women's Health (June 2024)
Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder
Article in Communications Biology (May 2024)